Europe Thalidomide Market Research Report Forecast 2017 to 2022

November 2017 | 122 pages | ID: E5C85EF8C5BEN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Europe Thalidomide Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Thalidomide industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Thalidomide market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Thalidomide Market Analysis by Countries:
Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:
Pfizer
Allergan
Alnylam Pharmaceuticals
Five Prime Therapeutics
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Enzon Pharmaceuticals
CASI Pharmaceuticals

Europe Thalidomide Market Analysis by Product:
Type 1
Type 2
Type 3

Europe Thalidomide Market Analysis by Application:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 THALIDOMIDE MARKET OVERVIEW

1.1 Product Overview and Scope of Thalidomide
1.2 Classification of Thalidomide
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Thalidomide
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Thalidomide Market States Status and Prospect (2012-2022) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Thalidomide (2012-2022)
  1.5.1 Europe Thalidomide Sales and Growth Rate (2012-2022)
  1.5.2 Europe Thalidomide Revenue and Growth Rate (2012-2022)

2 EUROPE ECONOMIC IMPACT ON THALIDOMIDE INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 THALIDOMIDE MANUFACTURING COST ANALYSIS

3.1 Thalidomide Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Thalidomide

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Thalidomide Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Thalidomide Major Manufacturers in 2016
4.4 Downstream Buyers

5 EUROPE THALIDOMIDE MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Thalidomide Market Competition by Manufacturers
  5.1.1 Europe Thalidomide Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Thalidomide Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Thalidomide (Volume and Value) by Type
  5.2.1 Europe Thalidomide Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Thalidomide Revenue and Market Share by Type (2012-2017)
5.3 Europe Thalidomide (Volume and Value) by Countries
  5.3.1 Europe Thalidomide Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Thalidomide Revenue and Market Share by Countries (2012-2017)
5.4 Europe Thalidomide (Volume) by Application

6 GERMANY THALIDOMIDE (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Thalidomide Sales and Value (2012-2017)
  6.1.1 Germany Thalidomide Sales and Growth Rate (2012-2017)
  6.1.2 Germany Thalidomide Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Thalidomide Sales Price Trend (2012-2017)
6.2 Germany Thalidomide Sales and Market Share by Manufacturers
6.3 Germany Thalidomide Sales and Market Share by Type
6.4 Germany Thalidomide Sales and Market Share by Application

7 FRANCE THALIDOMIDE (VOLUME, VALUE AND SALES PRICE)

7.1 France Thalidomide Sales and Value (2012-2017)
  7.1.1 France Thalidomide Sales and Growth Rate (2012-2017)
  7.1.2 France Thalidomide Revenue and Growth Rate (2012-2017)
  7.1.3 France Thalidomide Sales Price Trend (2012-2017)
7.2 France Thalidomide Sales and Market Share by Manufacturers
7.3 France Thalidomide Sales and Market Share by Type
7.4 France Thalidomide Sales and Market Share by Application

8 UK THALIDOMIDE (VOLUME, VALUE AND SALES PRICE)

8.1 UK Thalidomide Sales and Value (2012-2017)
  8.1.1 UK Thalidomide Sales and Growth Rate (2012-2017)
  8.1.2 UK Thalidomide Revenue and Growth Rate (2012-2017)
  8.1.3 UK Thalidomide Sales Price Trend (2012-2017)
8.2 UK Thalidomide Sales and Market Share by Manufacturers
8.3 UK Thalidomide Sales and Market Share by Type
8.4 UK Thalidomide Sales and Market Share by Application

9 RUSSIA THALIDOMIDE (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Thalidomide Sales and Value (2012-2017)
  9.1.1 Russia Thalidomide Sales and Growth Rate (2012-2017)
  9.1.2 Russia Thalidomide Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Thalidomide Sales Price Trend (2012-2017)
9.2 Russia Thalidomide Sales and Market Share by Manufacturers
9.3 Russia Thalidomide Sales and Market Share by Type
9.4 Russia Thalidomide Sales and Market Share by Application

10 ITALY THALIDOMIDE (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Thalidomide Sales and Value (2012-2017)
  10.1.1 Italy Thalidomide Sales and Growth Rate (2012-2017)
  10.1.2 Italy Thalidomide Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Thalidomide Sales Price Trend (2012-2017)
10.2 Italy Thalidomide Sales and Market Share by Manufacturers
10.3 Italy Thalidomide Sales and Market Share by Type
10.4 Italy Thalidomide Sales and Market Share by Application

11 SPAIN THALIDOMIDE (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Thalidomide Sales and Value (2012-2017)
  11.1.1 Spain Thalidomide Sales and Growth Rate (2012-2017)
  11.1.2 Spain Thalidomide Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Thalidomide Sales Price Trend (2012-2017)
11.2 Spain Thalidomide Sales and Market Share by Manufacturers
11.3 Spain Thalidomide Sales and Market Share by Type
11.4 Spain Thalidomide Sales and Market Share by Application

12 BENELUX THALIDOMIDE (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Thalidomide Sales and Value (2012-2017)
  12.1.1 Benelux Thalidomide Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Thalidomide Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Thalidomide Sales Price Trend (2012-2017)
12.2 Benelux Thalidomide Sales and Market Share by Manufacturers
12.3 Benelux Thalidomide Sales and Market Share by Type
12.4 Benelux Thalidomide Sales and Market Share by Application

13 EUROPE THALIDOMIDE MANUFACTURERS ANALYSIS

13.1 Pfizer
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Allergan
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Alnylam Pharmaceuticals
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Five Prime Therapeutics
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Angstrom Pharmaceuticals
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Acceleron Pharma
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Biocon
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Enzon Pharmaceuticals
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 CASI Pharmaceuticals
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE THALIDOMIDE MARKET FORECAST (2017-2022)

15.1 Germany Market Forecast (2017-2022)
15.2 France Market Forecast (2017-2022)
15.3 UK Market Forecast (2017-2022)
15.4 Russia Market Forecast (2017-2022)
15.5 Italy Market Forecast (2017-2022)
15.6 Spain Market Forecast (2017-2022)
15.7 Benelux Market Forecast (2017-2022)
15.8 Europe Thalidomide Market Forecast by Type (2017-2022)
15.9 Europe Thalidomide Market Forecast by Application (2017-2022)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Thalidomide
Table Classification of Thalidomide
Figure Europe Sales Market Share of Thalidomide by Type in 2016
Table Application of Thalidomide
Figure Europe Sales Market Share of Thalidomide by Application in 2016
Figure Germany Thalidomide Revenue and Growth Rate (2012-2022)
Figure France Thalidomide Revenue and Growth Rate (2012-2022)
Figure UK Thalidomide Revenue and Growth Rate (2012-2022)
Figure Russia Thalidomide Revenue and Growth Rate (2012-2022)
Figure Italy Thalidomide Revenue and Growth Rate (2012-2022)
Figure Spain Thalidomide Revenue and Growth Rate (2012-2022)
Figure Benelux Thalidomide Revenue and Growth Rate (2012-2022)
Figure Europe Thalidomide Sales and Growth Rate (2012-2022)
Figure Europe Thalidomide Revenue and Growth Rate (2012-2022)
Table Europe Thalidomide Sales of Key Manufacturers (2015 and 2016)
Table Europe Thalidomide Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Thalidomide Sales Share by Manufacturers
Figure 2016 Thalidomide Sales Share by Manufacturers
Table Europe Thalidomide Revenue by Manufacturers (2015 and 2016)
Table Europe Thalidomide Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Thalidomide Revenue Share by Manufacturers
Table 2016 Europe Thalidomide Revenue Share by Manufacturers
Table Europe Thalidomide Sales and Market Share by Type (2012-2017)
Table Europe Thalidomide Sales Share by Type (2012-2017)
Figure Sales Market Share of Thalidomide by Type (2012-2017)
Figure Europe Thalidomide Sales Growth Rate by Type (2012-2017)
Table Europe Thalidomide Revenue and Market Share by Type (2012-2017)
Table Europe Thalidomide Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Thalidomide by Type (2012-2017)
Figure Europe Thalidomide Revenue Growth Rate by Type (2012-2017)
Table Europe Thalidomide Sales and Market Share by Countries (2012-2017)
Table Europe Thalidomide Sales Share by Countries (2012-2017)
Figure Sales Market Share of Thalidomide by Countries (2012-2017)
Table Europe Thalidomide Revenue and Market Share by Countries (2012-2017)
Table Europe Thalidomide Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Thalidomide by Countries (2012-2017)
Table Europe Thalidomide Sales and Market Share by Application (2012-2017)
Table Europe Thalidomide Sales Share by Application (2012-2017)
Figure Sales Market Share of Thalidomide by Application (2012-2017)
Figure Germany Thalidomide Sales and Growth Rate (2012-2017)
Figure Germany Thalidomide Revenue and Growth Rate (2012-2017)
Figure Germany Thalidomide Sales Price Trend (2012-2017)
Table Germany Thalidomide Sales by Manufacturers (2015 and 2016)
Table Germany Thalidomide Market Share by Manufacturers (2015 and 2016)
Table Germany Thalidomide Sales by Type (2015 and 2016)
Table Germany Thalidomide Market Share by Type (2015 and 2016)
Table Germany Thalidomide Sales by Application (2015 and 2016)
Table Germany Thalidomide Market Share by Application (2015 and 2016)
Figure France Thalidomide Sales and Growth Rate (2012-2017)
Figure France Thalidomide Revenue and Growth Rate (2012-2017)
Figure France Thalidomide Sales Price Trend (2012-2017)
Table France Thalidomide Sales by Manufacturers (2015 and 2016)
Table France Thalidomide Market Share by Manufacturers (2015 and 2016)
Table France Thalidomide Sales by Type (2015 and 2016)
Table France Thalidomide Market Share by Type (2015 and 2016)
Table France Thalidomide Sales by Application (2015 and 2016)
Table France Thalidomide Market Share by Application (2015 and 2016)
Figure UK Thalidomide Sales and Growth Rate (2012-2017)
Figure UK Thalidomide Revenue and Growth Rate (2012-2017)
Figure UK Thalidomide Sales Price Trend (2012-2017)
Table UK Thalidomide Sales by Manufacturers (2015 and 2016)
Table UK Thalidomide Market Share by Manufacturers (2015 and 2016)
Table UK Thalidomide Sales by Type (2015 and 2016)
Table UK Thalidomide Market Share by Type (2015 and 2016)
Table UK Thalidomide Sales by Application (2015 and 2016)
Table UK Thalidomide Market Share by Application (2015 and 2016)
Figure Russia Thalidomide Sales and Growth Rate (2012-2017)
Figure Russia Thalidomide Revenue and Growth Rate (2012-2017)
Figure Russia Thalidomide Sales Price Trend (2012-2017)
Table Russia Thalidomide Sales by Manufacturers (2015 and 2016)
Table Russia Thalidomide Market Share by Manufacturers (2015 and 2016)
Table Russia Thalidomide Sales by Type (2015 and 2016)
Table Russia Thalidomide Market Share by Type (2015 and 2016)
Table Russia Thalidomide Sales by Application (2015 and 2016)
Table Russia Thalidomide Market Share by Application (2015 and 2016)
Figure Italy Thalidomide Sales and Growth Rate (2012-2017)
Figure Italy Thalidomide Revenue and Growth Rate (2012-2017)
Figure Italy Thalidomide Sales Price Trend (2012-2017)
Table Italy Thalidomide Sales by Manufacturers (2015 and 2016)
Table Italy Thalidomide Market Share by Manufacturers (2015 and 2016)
Table Italy Thalidomide Sales by Type (2015 and 2016)
Table Italy Thalidomide Market Share by Type (2015 and 2016)
Table Italy Thalidomide Sales by Application (2015 and 2016)
Table Italy Thalidomide Market Share by Application (2015 and 2016)
Figure Spain Thalidomide Sales and Growth Rate (2012-2017)
Figure Spain Thalidomide Revenue and Growth Rate (2012-2017)
Figure Spain Thalidomide Sales Price Trend (2012-2017)
Table Spain Thalidomide Sales by Manufacturers (2015 and 2016)
Table Spain Thalidomide Market Share by Manufacturers (2015 and 2016)
Table Spain Thalidomide Sales by Type (2015 and 2016)
Table Spain Thalidomide Market Share by Type (2015 and 2016)
Table Spain Thalidomide Sales by Application (2015 and 2016)
Table Spain Thalidomide Market Share by Application (2015 and 2016)
Figure Benelux Thalidomide Sales and Growth Rate (2012-2017)
Figure Benelux Thalidomide Revenue and Growth Rate (2012-2017)
Figure Benelux Thalidomide Sales Price Trend (2012-2017)
Table Benelux Thalidomide Sales by Manufacturers (2015 and 2016)
Table Benelux Thalidomide Market Share by Manufacturers (2015 and 2016)
Table Benelux Thalidomide Sales by Type (2015 and 2016)
Table Benelux Thalidomide Market Share by Type (2015 and 2016)
Table Benelux Thalidomide Sales by Application (2015 and 2016)
Table Benelux Thalidomide Market Share by Application (2015 and 2016)
Table Pfizer Basic Information List
Table Pfizer Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Thalidomide Sales Market Share (2012-2017)
Table Allergan Basic Information List
Table Allergan Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
Table Allergan Thalidomide Sales Market Share (2012-2017)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Alnylam Pharmaceuticals Thalidomide Sales Market Share (2012-2017)
Table Five Prime Therapeutics Basic Information List
Table Five Prime Therapeutics Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
Table Five Prime Therapeutics Thalidomide Sales Market Share (2012-2017)
Table Angstrom Pharmaceuticals Basic Information List
Table Angstrom Pharmaceuticals Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Angstrom Pharmaceuticals Thalidomide Sales Market Share (2012-2017)
Table Acceleron Pharma Basic Information List
Table Acceleron Pharma Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
Table Acceleron Pharma Thalidomide Sales Market Share (2012-2017)
Table Biocon Basic Information List
Table Biocon Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biocon Thalidomide Sales Market Share (2012-2017)
Table Enzon Pharmaceuticals Basic Information List
Table Enzon Pharmaceuticals Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
Table Enzon Pharmaceuticals Thalidomide Sales Market Share (2012-2017)
Table CASI Pharmaceuticals Basic Information List
Table CASI Pharmaceuticals Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
Figure CASI Pharmaceuticals Thalidomide Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Thalidomide
Figure Manufacturing Process Analysis of Thalidomide
Figure Thalidomide Industrial Chain Analysis
Table Raw Materials Sources of Thalidomide Major Manufacturers in 2016
Table Major Buyers of Thalidomide
Table Distributors/Traders List
Figure Germany Thalidomide Sales and Growth Rate Forecast (2017-2022)
Figure Germany Thalidomide Revenue and Growth Rate Forecast (2017-2022)
Figure France Thalidomide Sales and Growth Rate Forecast (2017-2022)
Figure France Thalidomide Revenue and Growth Rate Forecast (2017-2022)
Figure UK Thalidomide Sales and Growth Rate Forecast (2017-2022)
Figure UK Thalidomide Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Thalidomide Sales and Growth Rate Forecast (2017-2022)
Figure Russia Thalidomide Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Thalidomide Sales and Growth Rate Forecast (2017-2022)
Figure Italy Thalidomide Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Thalidomide Sales and Growth Rate Forecast (2017-2022)
Figure Spain Thalidomide Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Thalidomide Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Thalidomide Revenue and Growth Rate Forecast (2017-2022)
Table Europe Thalidomide Sales Forecast by Type (2017-2022)
Table Europe Thalidomide Sales Forecast by Application (2017-2022)

COMPANIES MENTIONED

Pfizer
Allergan
Alnylam Pharmaceuticals
Five Prime Therapeutics
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Enzon Pharmaceuticals
CASI Pharmaceuticals
Celgene Corporation